Aspiration to obtain osteoblast progenitor cells from human bone marrow: The influence of aspiration volume

Journal of Bone and Joint Surgery

Volumn 79, Issue 11, 1997, Pages 1699-1709

  Muschler, George F ^a   Boehm, Cynthia ^a   Easley, Kirk ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE GRAFT; BONE TUMOR; CLINICAL ARTICLE; COLONY FORMING UNIT; COXITIS; FEMALE; FRACTURE; HEMATOPOIETIC STEM CELL; HUMAN; ILIAC CREST; MALE; OSTEOARTHRITIS; OSTEOBLAST; PRIORITY JOURNAL; PSEUDARTHROSIS;

EID: 0030702126     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-199711000-00012     Document Type: Article

References (65)

1. Andrianarivo, A. G.; Robinson, J. A.; Mann, K. G.; and Tracy, R. P.: Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J. Cell. Physiol., 153: 256-265, 1992.
2. Ashton, B. A.; Abdultah, F.; Cave, J.; Williamson, M.; Sykes, B. C.; Couch, M.; and Poser, J. W.: Characterization of cells with high alkaline phosphatase activity derived from human bone and marrow: preliminary assessment of their osteogenicity. Bone, 6: 313-319, 1985.
3. Bellows, C. G.; Aubin, J. E.; Heersche, J. N.; and Antosz, M. E.: Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif. Tissue Internat., 38: 143-154, 1986.
4. 3 stimulates adipocyte differentiation in cultures of fetal rat calvaria cells: comparison with the effects of dexamethasone. Endocrinology, 134: 2221-2229, 1994.
5. Bennett, J. H.; Joyner, C. J.; Triffitt, J. T.; and Owen, M. E.: Adipocytic cells cultured from marrow have osteogenic potential. J. Cell Sci., 99: 131-139, 1991.
6. Beresford, J. N.: Osteogenic stem cells and the stromal system of bone and marrow. Clin. Orthop., 240: 270-280, 1989.
7. Beresford, J. N.; Bennett, J. H.; Devlin, C.; Leboy, P. S.; and Owen, M. E.: Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J. Cell Sci., 102: 341-351, 1992.
8. Bianco, P.; Riminucci, M.; Silvestrini, G.; Bonucci, E.; Termine, J. D.; Fisher, L. W.; and Robey, P. G.: Localization of bone sialoprotein (BSP) to Golgi and post-Golgi secretory structures in osteoblasts and to discrete sites in early bone matrix. J. Histochem. and Cytochem., 41: 193-203, 1993.
9. Bostrom, K.; Watson, K. E.; Horn, S.; Wortham, C.; Herman, I. M.; and Demer, L. L.: Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest., 91: 1800-1809, 1993.
10. Brighton, C. T.; Lorich, D. G.; Kupcha, R.; Reilly, T. M.; Jones, A. R.; and Woodbury, R. A., II: The pericyte as a possible osteoblast progenitor cell. Clin. Orthop., 275: 287-299, 1992.
11. Bucholz, R. W.; Carlton, A.; and Holmes, R.: Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin. Orthop., 240: 53-62, 1989.
12. Burwell, R. G.: The function of bone marrow in the incorporation of a bone graft. Clin. Orthop., 200: 125-141, 1985.
13. Caplan, A. I.: Mesenchymal stem cells. J. Orthop. Res., 9: 641-650, 1991.
14. Chiba, H.; Sawada, N.; Ono, T.; Ishii, S.; and Mori, M.: Establishment and characterization of a simian virus 40-immortalized osteoblastic cell line from normal human bone. Japanese J. Cancer Res., 84: 290-297, 1993.
15. Connolly, J.; Guse, R.; Lippiello, L.; and Dehne, R.: Development of an osteogenic bone-marrow preparation. J. Bone and Joint Surg., 71-A: 684-691, June 1989.
16. Connolly, J. F.; Guse, R.; Tiedeman, J.; and Dehne, R.: Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin. Orthop., 266: 259-270, 1991.
17. Cook, S. D.; Baffes, G. C.; Wolfe, M. W.; Sampath, T. K.; and Rueger, D. C.: Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin. Orthop., 301: 302-312, 1994.
18. Cook, S. D.; Dalton, J. E.; Tan, E. H.; Whitecloud, T. S., III; and Rueger, D. C.: In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine, 19: 1655-1663, 1994.
19. Cook, S. D.; Baffes, G. C.; Wolfe, M. W.; Sampath, T. K.; Rueger, D. C.; and Whitecloud, T. S., III: The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J. Bone and Joint Surg., 76-A: 827-838, June 1994.
20. Cornell, C. N.; Lane, J. M.; Chapman, M.; Merkow, R.; Seligson, D.; Henry, S.; Gustilo, R.; and Vincent, K.: Multicenter trial of Collagraft as bone graft substitute. J. Orthop. Trauma, 5: 1-8, 1991.
21. Diaz-Flores, L.; Gutierrez, R.; Lopez-Alonso, A.; Gonzalez, R.; and Varela, H.: Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. Clin. Orthop., 275: 280-286, 1992.
22. Dorheim, M. A.; Sullivan, M.; Dandapani, V.; Wu, X.; Hudson, J.; Segarini, P. R.; Rosen, D. M.; Aulthouse, A. L.; and Gimble, J. M.: Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. J. Cell. Physiol., 154: 317-328, 1993.
23. Friedenstein, A. J.: Determined and inducible osteogenic precursor cells. In Hard Tissue Growth, Repair and Remineralization. Ciba Foundation Symposium 11 (new series), pp. 169-182. Edited by R. Sognaes and J. Vaughan. New York, Elsevier, 1973.
24. Friedenstein, A. J.: Precursor cells of mechanocytes. Internat. Rev. Cytol., 47: 327-359, 1976.
25. Friedenstein, A. J.; Petrakova, K. V.; Kurolesova, A. I.; and Frolova, G. P.: Heterotopic transplants of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, 6: 230-247, 1968.
26. Friedenstein, A. J.; Chailakhyan, R. K.; Latsinik, N. V.; Panasyuk, A. F.; and Keiliss-Borok, I. V.: Stromal cells responsible for transferring the microenvironment of the haemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation, 17: 331-340, 1974.
27. Gerhart, T. N.; Kirker-Head, C. A.; Kriz, M. J.; Holtrop, M. E.; Hennig, G. E.; Hipp, J.; Schelling, S. H.; and Wang, E.: Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin. Orthop., 293: 317-326, 1993.
28. Grigoriadis, A. E.; Heersche, J. N.; and Aubin, J. E.: Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J. Cell Biol., 106: 2139-2151, 1988.
29. Haynesworth, S. E.; Baber, M. A.; and Caplan, A. I.: Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone, 13: 69-80, 1992.
30. Haynesworth, S. E.; Goshima, J.; Goldberg, V. M.; and Caplan, A. I.: Characterization of cells with osteogenic potential from human marrow. Bone, 13: 81-88, 1992.
31. Healey, J. H.; Zimmerman, P. A.; McDonnell, J. M.; and Lane, J. M.: Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin. Orthop., 256: 280-285, 1990.
32. Ishida, H.; Bellows, C. G.; Aubin, J. E.; and Heersche, J. N.: Characterization of the 1,25-(OH)2D3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvaria cells. Endocrinology, 132: 61-66, 1993.
33. Johnson, K. A.; Howlett, C. R.; Bellenger, C. R.; and Armati-Gulson, P.: Osteogenesis by canine and rabbit bone marrow in diffusion chambers. Calcif. Tissue Internat., 42: 113-118, 1988.
34. Lajeunesse, D.; Kiebzak, G. M.; Frondoza, C.; and Sacktor, B.: Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone and Min., 14: 237-250, 1991.
35. Lane, J. M.; Muschler, G. F.; Werntz, J.; Nottebaert, M.; Gebhart, M.; Piergentili, C.; and Burstein, A.: The use of composite bone graft materials in a segmental femoral defect model in the rat. J. Orthop. Trauma, 2: 57-58, 1988.
36. Lindholm, T. S., and Urist, M. R.: A quantitative analysis of new bone formation by induction in composite grafts of bone marrow and bone matrix. Clin. Orthop., 150: 288-300, 1980.
37. Longbotham, C. F.: Nonparametric density estimation. In SUGI 12. Proceedings of the Twelfth Annual SAS Users Group International Conference, Dallas, Texas, February 8-11, 1987. Cary, North Carolina, SAS Institute, 1987.
38. Majors, A. K.; Ehrhart, L. A.; and Muschler, G. F.: Basic fibroblast growth factor enhances proliferation and reversibly inhibits osteoblastic differentiation of human bone marrow stromal cells in primary culture. Unpublished data.
39. Majors, A. K.; Boehm, C. A.; Nitto, H.; Midura, R. J.; and Muschler, G. F.: Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J. Orthop. Res., 15: 546-557, 1997.
40. Maniatopoulos, C.; Sodek, J.; and Melcher, A. H.: Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell and Tissue Res., 254: 317-330, 1988.
41. Meunier, P.; Aaron, J.; Edouard, C.; and Vignon, G.: Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin. Orthop., 80:147-154, 1971.
42. Midura, R. J., and Lembke, L. A.: Parathyroid hormone inhibits bone mineral formation in an osteoblastic cell line. Trans. Orthop. Res. Soc., 20:451, 1995.
43. Muschler, G. F., and Lane, J. M.: Clinical applications of bone grafting in orthopaedic surgery. In Bone Grafting - from Basic Science to Clinical Application, pp. 375-407. Edited by M. B. Habal and A. H. Reddi. New York, W. B. Saunders, 1992.
44. Muschler, G. F.; Hyodo, A.; Manning, T.; Kambic, H.; and Easley, K.: Evaluation of human bone morphogenetic protein 2 in a canine spinal fusion model. Clin. Orthop., 308: 229-240, 1994.
45. Nade, S., and Burwell, R. G.: Decalcified bone as a substrate for osteogenesis. An appraisal of the interrelation of bone and marrow in combined grafts. J. Bone and Joint Surg., 59-B(2): 189-196, 1977.
46. Nade, S.; Armstrong, L.; McCartney, E.; and Baggaley, B.: Osteogenesis after bone and bone marrow transplantation. The ability of ceramic materials to sustain osteogenesis from transplanted bone marrow cells: preliminary studies. Clin. Orthop., 181: 255-263, 1983.
47. Nakahara, H.; Dennis, J. E.; Bruder, S. P.; Haynesworth, S. E.; Lennon, D. P.; and Caplan, A. I.: In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exper. Cell Res., 195: 492-503, 1991.
48. Nathan, R. M.; Bentz, H.; Armstrong, R. M.; Piez, K. A.; Smestad, T. L.; Ellingsworth, L. R.; McPherson, J. M.; and Seyedin, S. M.: Osteogenesis in rats with an inductive bovine composite. J. Orthop. Res., 6: 324-334, 1988.
49. Ohgushi, H.; Goldberg, V. M.; and Caplan, A. I.: Heterotopic osteogenesis in porous ceramics induced by marrow cells. J. Orthop. Res., 7: 568-578, 1989.
50. Ohgushi, H.; Goldberg, V. M.; and Caplan, A. I.: Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop. Scandinavica, 60: 334-339, 1989.
51. Owen, M.: Lineage of osteogenic cells and their relationship to the stromal system. In Bone and Mineral Research, edited by W. A. Peck. Vol. 3, pp. 1-25. New York, Elsevier, 1985.
52. Owen, M.: Marrow stromal stem cells. J. Cell Sci., 10 (Supplement): 63-76, 1988.
53. Owen, M., and Friedenstein, A. J.: Stromal stem cells: marrow-derived osteogenic precursors. In Cell and Molecular Biology of Vertebrate Hard Tissues. Ciba Foundation Symposium, pp. 42-53. New York, Wiley, 1988.
54. Paley, D.; Young, M. C.; Wiley, A. M.; Fornasier, V. L.; and Jackson, R. W.: Percutaneous bone marrow grafting of fractures and bony defects. An experimental study in rabbits. Clin. Orthop., 208: 300-312, 1986.
55. Pfeiffer, C. A.: Development of bone from transplanted marrow in mice. Anat. Rec., 102: 225-240, 1948.
56. Ragni, P.; Lindholm, T. S.; and Lindholm, T. C.: Vertebral fusion dynamics in the thoracic and lumbar spine induced by allogenic demineralized bone matrix combined with autogenous bone marrow. An experimental study in rabbits. Italian J. Orthop. and Traumatol., 13: 241-251, 1987.
57. Rickard, D. J.; Kassem, M.; Hefferan, T. E.; Sarkar, G.; Spelsberg, T. C.; and Riggs, B. L.: Isolation and characterization of osteoblast precursor cells from human bone marrow. J. Bone and Min. Res., 11: 312-324, 1996.
58. Schmidt, R., and Kulbe, K. D.: Long-term cultivation of human osteoblasts. Bone and Min., 20: 211-221, 1993.
59. Simmons, D. J.; Ellsasser, J. C.; Cummins, H.; and Lesker, P.: The bone inductive potential of a composite bone allograft-marrow autograft in rabbits. Clin. Orthop., 97: 237-247, 1973.
60. Takagi, K., and Urist, M. R.: The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. Clin. Orthop., 171: 224-231, 1982.
61. Tiedeman, J. J.; Connolly, J. F.; Strates, B. S.; and Lippiello, L.: Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix. An experimental study in dogs. Clin. Orthop., 268: 294-302, 1991.
62. Turksen, K., and Aubin, J. E.: Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J. Cell Biol., 114: 373-384, 1991.
63. Yamaguchi, A., and Kahn, A. J.: Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif. Tissue Internat., 49: 221-225, 1991.
64. Yasko, A. W.; Lane, J. M.; Fellinger, E. J.; Rosen, V.; Wozney, J. M.; and Wang, E. A.: The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J. Bone and Joint Surg., 74-A: 659-670, June 1992.
65. Yasko, A. W.; Cole, B. J.; Lane, J. M.; Tomin, M.; Peterson, M.; Ron, E.; Turek, T.; and Wang, E. A.: Comparison of recombinant human BMP-2 versus cancellous bone to heal segmental bone defects. Trans. Orthop. Res. Soc., 18: 100, 1993.